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ABSTRACT 
 Background and aims: Previous analyses have highlighted significant associations 
between GD/subsyndromal GD and increased rates of anxiety symptoms and anxiety disorders 
relative to the general population. However less is known about how anxiety symptoms influence 
the clinical presentation of gambling problems The objective of the current study was to evaluate 
the association between anxiety symptoms, gambling activity and neurocognition across the 
spectrum of gambling behavior. 
 Methods: The sample consisted of 143 non-treatment-seeking young adults (aged 18 to 
29). Sixty-three individuals (44.1%) were classified as recreational gamblers, 47 (32.9%) as 
having subsyndromal GD, and 33 (23.1%) met criteria for GD. 
Results: The main findings were: 1) there was a positive correlation between anxiety 
severity and gambling severity measured by number of DSM 5 GD criteria met; 2) there was a 
positive correlation between anxiety severity and attentional impulsiveness; 3) subjects with 
suicidality presented higher levels of anxiety; and 4) the severity of anxiety symptoms was 
negatively correlated with quality of life.   
 Conclusions: This study suggests that anxiety may be associated with relevant clinical 
variables in the broad spectrum of gambling activity. Therefore, proper management of anxiety 
symptoms might improve the clinical presentation of gamblers in different areas. 
 
KEYWORDS: Gambling disorder; subsyndromal gambling; problem gambling; anxiety; 
neurocognition. 
 
1. INTRODUCTION 
Gambling disorder (GD) is associated with high rates of depression, substance-use 
disorders, and suicidality; as well as occupational and legal problems (Bland et al., 
1993; Cunningham-Williams et al., 1998; Petry and Kiluk, 2002; Muelleman et al., 2002; Toce-
Gerstein et al., 2003, Petry et al., 2005). The annual cost of GD is approximately 5 billion US 
dollars within the United States alone (National Gambling Impact Study Commission; 1999). 
Subsyndromal gambling is also a notable concern, and is defined as significant gambling activity 
that does not meet full DSM-5 criteria for GD (Grant et al., 2014). Subsyndromal gamblers also 
show high rates of depression, anxiety disorders, substance-use disorders, financial, legal, family 
and professional problems (Cunningham-Williams et al., 1998; Gerstein et al., 1999; Shaffer and 
Korn, 2002; Welte et al., 2001; Desai et al., 2004; Potenza et al., 2006; Grall-Bronnec et al., 
2012). Therefore, it is likely that gambling symptoms present on a continuum, and that 
symptoms should be assessed across the spectrum of gambling behavior (Cunningham-Williams 
et al., 1998; Gerstein et al., 1999; Shaffer et al., 1999; Slutske et al., 2000; Welte et al., 2001; 
Eisen et al., 2001; Shaffer and Korn, 2002; Toce-Gerstein et al., 2003; Grant et al., 2014). 
Previous analyses have highlighted significant associations between GD/subsyndromal 
GD and increased rates of anxiety symptoms and anxiety disorders relative to the general 
population (Bland et al., 1993; Black and Moyer, 1998; Cunningham-Williams et al., 1998; Petry 
et al., 2005; Desai and Potenza, 2008). One large epidemiological study found a lifetime 
prevalence of anxiety disorders of 41.3% among disordered gamblers (Petry et al., 2005). A 
systematic review of epidemiological studies corroborated these findings, with 37% of gamblers 
reporting a history of a comorbid anxiety disorder (Lorains et al., 2011). In another analysis, 
Desai and Potenza (2008) also found a high prevalence of panic disorder, generalized anxiety 
and social phobia in subsyndromal GD.  
Although anxiety symptoms are common in gamblers, less is known about how anxiety 
symptoms influence the clinical presentation of gambling problems. Various lines of research   
suggest that anxiety could be a powerful contributor to gambling behavior. First, research in 
other addictions (alcohol-use disorder and substance-use disorder) suggests that the behavior 
may be a way to cope anxiety (Sher et al., 1994).  The relief of the anxiety, however, tends to be 
short-lived, and the symptoms may often reappear more intensely. As a result, a harmful cycle is 
created, and the anxious individual may therefore present with a more frequent and severe form 
of the addictive behavior. Second, attentional bias toward threatening elements is a well 
characterized phenomenon in anxious individuals and, as a result of this, other non-threatening 
elements tend to be less perceived (MacLeod et al., 1986; Mogg & Bradley; 1998, Bishop et al., 
2004; Koster et al., 2004; Koster et al., 2006, Bar-Haim et al., 2007, Schofield et al., 2012). 
Therefore, an anxious individual who gambles may have a reduced focus on the gambling 
behavior (i.e. how to bet, how much to bet). This attentional deficit may be another factor 
leading to a worse severity of GD.  Finally, anxiety symptoms decrease some dimensions of 
quality of life (Spitzer et al., 1995). In this context, the increased emotional suffering and the 
lower level of life satisfaction could also increase the risk of suicide.  
In light of this background, the objective of the current study was to evaluate the 
association between anxiety symptoms, gambling activity and neurocognition across the 
spectrum of gambling behavior (recreational gamblers, subsyndromal GD and GD) in a non-
treatment seeking sample. We assessed the current severity of anxiety symptoms and 
associations between anxiety symptom severity, gambling symptoms, impulsiveness, and 
neurocognition. We predicted that anxiety symptoms would be associated with 1) worse overall 
severity of GD, measured by increased gambling activity and more losses due to gambling, and 
2) higher impulsivity measured with clinical and neurocognitive tasks. Additionally, we expected 
that anxiety would be correlated with 3) worse clinical and neurocognitive attentional 
performance, 4) lower quality of life and 5) higher levels of suicidality. If our hypotheses are 
correct, anxiety symptoms would be associated with variables correlated with poor prognosis and 
poor overall functioning. Therefore, proper management of anxiety should receive greater 
attention in clinical practice since it could improve the clinical presentation of gamblers in 
multiple domains. If our hypotheses are not supported, constant assessment and treatment of 
anxiety would be a secondary approach in the management of GD. 
 
2. METHODS 
2.1 Sample 
The sample consisted of 143 non-treatment-seeking young adults (aged 18 to 29) [n=75 
(52.1%) male; mean age 24.8 (±2.9) yrs] with varying levels of gambling severity. Participants 
were recruited through media advertising (“have you ever gambled?”), and had gambled at least 
five times during the past year. Sixty-three individuals (44.1%) were classified as recreational 
gamblers (see later for definitions), 47 (32.9%) as having subsyndromal GD, and 33 (23.1%) met 
criteria for GD.  
 
2.2 Procedures 
All assessments were completed as a part of an ongoing study of gambling behavior in 
young adults. Participants were compensated with a US$50 gift card to a local department 
store.  Subjects were recruited in Chicago/IL and Minneapolis/MN metropolitan areas. Exclusion 
criteria included inability to complete study procedures, inability/unwillingness to provide 
voluntary written informed consent, and gambling frequency of less than five times in the past 
year. No medications were administered as part of this study. Subjects taking medications were 
allowed to take part in the research.  
 
2.3 Measurements 
2.3.1 Demographics 
Age, gender, marital status, educational status, professional status, ethnicity and sexual 
orientation were recorded.  
2.3.2 Severity of anxiety symptoms 
The Hamilton Anxiety Scale (HAM-A) is a valid and reliable instrument that assesses 
cross-sectional severity of anxiety symptoms (Hamilton, 1969; Snaith et al., 1982; Maier et al., 
1988). The HAM-A consists of 14 items (score range 0 to 56) that evaluate a variety of anxiety 
symptoms (Beck and Steer, 1991). HAM-A total score presents an intraclass coefficient of 0.74 
and a concurrent validity between 0.63 and 0.75 (Maier et al., 1988). The HAM-A has shown 
good internal consistency [Cronbach’s alpha = 0.893] (Kummer et al., 2010). It is probably the 
most used and accepted scale to evaluate anxiety symptoms. 
2.2.3 Clinical variables  
a) Gambling behavior: We evaluated the age at start of regular gambling, the amount of money 
lost with gambling in the last year and the average gambling frequency (times per week).  
b) Overall Severity of GD: we assessed the total number of DSM-5 GD criteria using the 
Structured Clinical Interview for Gambling Disorder [SCI-PG] (Grant et al., 2004). SCI-PG was 
first validated using the criteria of the Fourth Edition of the Diagnostic and Statistical Manual of 
Mental Disorders [DSM-4]. Test-retest reliability on the number of GD criteria endorsed showed 
r = 0.97 [p = .006] (Grant et al., 2004). We retrospectively processed the electronic saved DSM 4 
criteria for a proper adaptation to DSM-5. This procedure was performed deleting the criterion 
“committed illegal acts such as forgery, fraud, theft, or embezzlement to finance gambling 
regarding illegal acts”, which was present in previous manual, DSM-4. Moreover, we lowered 
the diagnostic threshold from five to four, consistent with DSM-5. Remaining criteria were 
unchanged. Severity was divided in three categories: recreational gambling (meets 0 DSM-5 
criteria), subsyndromal GD (meets 1 to 3 DSM-5 criteria) and GD (meets 4 or more DSM-5 
criteria). 
Additionally, we investigated the overall gambling severity with the Pathological 
Gambling Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). It is a 10-item scale that 
showed high validity [r = .895] and reliability [Cronbach’s α = .970] (Pallanti et al., 2005). This 
scale provides a total score (overall severity) as well as scores in 2 subscales (urges subscale and 
behavior subscale).  
c) Impulsiveness: evaluated by the Barratt Impulsiveness Scale, version 11 [BIS- 11] (Patton et 
al., 1995), a scale that has been largely used to investigate impulsiveness (Steinberg et al., 2013). 
This scale has shown good internal consistency [Cronbach α between 0.79 and 0.83] (Patton et 
al., 1995). BIS-11 provides scores in three different dimensions, based on previous factor 
analyses: [attentional impulsiveness], [motor impulsiveness] and [Non-planning impulsiveness] 
(Patton et al., 1995).  
d) Prevalence of illegal acts: the commitment of illegal acts to finance gambling activity has 
been associated with higher severity of GD (Toce-Gerstein, 2003; Strong and Kahler, 2007; 
Granero et al., 2014). It was evaluated using an open question using previous DSM-4 criteria: 
“Have you committed illegal acts such as forgery, fraud, theft or embezzlement to finance 
gambling?” 
e) Suicidality and psychiatric comorbidity: evaluated by the Mini International Neuropsychiatric 
Interview [MINI] - (Sheeran et al., 1998).  
f) Quality of life (Quality of life inventory): a 17-item scale that evaluates subject’s overall 
quality of life (Frisch, 1994). Alpha coefficients and test-retest correlations for this questionnaire 
have ranged, respectively, from 0.77 to 0.89 and from 0.80 to 0.91 (Mendlowicz and Stein, 
2014). 
g) Use of nicotine: assessed by a 20-cigarettes pack per day equivalent.  
 
2.3.4 Neurocognitive testing 
Individuals with GD tend to present with several neurocognitive deficits such as poorer 
response inhibition, low cognitive flexibility, worse decision-making and problems with 
sustained attention and executive functioning (Clark, 2010; Van Holst et al., 2010). This study 
evaluated whether anxiety symptoms affected any of these neuropsychological variables. In this 
context, participants undertook selected tests from the computerized Cambridge 
Neuropsychological Test Automated Battery [CANTABeclipse, version 3, Cambridge Cognition 
Ltd, Cambridge, UK] (Cambridge Cognition, 2015). Task order was fixed and the total duration 
of cognitive testing was approximately 50 min.  
a) Response inhibition: assessed by the Stop-signal task, which assesses the subject's ability to 
inhibit/suppress motor responses. Individuals react to an arrow stimulus, by touching either a 
left- or right-key depending on the direction in which the arrow points. When an audio tone 
occurs, the participant attempts to suppress their motor response for the particular trial (Morein-
Zanir, 2010). The outcome measure of interest is the stop-signal reaction time, an index of the 
time taken for the person’s brain to stop a response that would normally be made.  
b) Cognitive flexibility: investigated with the Intra-Dimensional /Extra-Dimensional set shifting 
test, which evaluates rule learning, reversal, and shifting of attentional focus across stimulus 
dimensions. The test uses visual stimuli (colorful shapes and white lines) and gives feedback to 
the individual so that they are able to learn an underlying ‘rule’ about which stimulus is correct, 
based on trial and error. The underlining rule that determines what is “correct” and incorrect” 
changes several times and assesses the individual’s ability to respond flexibility (Cambrigde 
Cognition, 2015). The adjusted total number of errors is an overall score of performance.  
c) Decision making: assessed using the Cambridge Gamble Task, a test that assesses decision-
making and risk-taking (Deakin et al., 2004; Lawrence et al., 2009, Cambridge cognition, 2015). 
The task simulates gambling activity but uses points for bets, rather than ‘real’ rewards. The 
main outcome measures in this test are: quality of decision-making, proportion of points gambled 
and risk adjustment.  
d) Sustained attention: evaluated by the Rapid Visual Information Processing paradigm. This 
task investigates the ability to detect unpredictable target sequences over prolonged periods of 
time (Sarter et al., 2001). The task consists of a white box in the center of the computer screen, 
inside which numbers, from 2 to 9, show up in a pseudo-random manner, at the frequency of 100 
digits/minute. A’ prime was used as measure of sustained attention. 
e) Executive functioning: assessed using the One touch stockings of Cambridge task. This test, a 
variant of a variation of the Tower of London (Owen et al., 1995), investigates goal-directed 
planning (Cambridge Cognition, 2015). The task presents visual problems to the subject and 
evaluates the individual’s ability to plan a solution and answer these problems.  
2.4 Statistical analysis 
We analyzed the association between severity of anxiety symptoms and demographic, 
clinical and neurocognitive variables of the participants using Spearman´s coefficients for 
continuous elements and Mann-Whitney tests for categorical variables.  
To control for multiple comparisons, we divided the usual level of significance (p = .05) 
by the number of variables evaluated in each group of assessments (i.e. [clinical variables] and 
[neurocognitive testing]). Consequently, significance was defined as p ≤ .004 (0.05/13 = 0.004) 
for [clinical variables]; p ≤ .007 (0.05/7 = 0.007) [neurocognitive variables]. 
 In order to reduce the likelihood of confounding variables contributing to the above 
analyses, we controlled for current major depressive disorder, alcohol-use disorder, substance-
use disorder, and nicotine use. These controls were included, as all four variables have 
demonstrated significant overlap with anxiety symptoms and several clinical/neurocognitive 
variables investigated in this study, in prior work (Maier et al., 1988; Clark, 2010).  
2.5 Ethics 
This research was approved by the Institutional Review Boards of the University of 
Chicago and the University of Minnesota. Study procedures were explained to participants prior 
to providing consent, and all participants were given time to ask questions. All participants 
provided written informed consent.  
 
3. RESULTS 
            Table 1 describes the demographics and main clinical variables of our sample. 
TABLE 1 HERE 
There was a significant positive correlation between the severity of anxiety symptoms 
and the number of current DSM 5 GD criteria. Additionally, quality of life was negatively 
correlated with the severity of anxiety symptoms. The presence of suicidality in gamblers was 
also associated with significantly higher scores on HAM-A, even after controlling for major 
depression, alcohol use-disorders, substance-use disorder, and use of nicotine (see also findings 
using ANOVA, Figure 1). The analysis also showed a direct correlation between anxiety 
symptoms in gamblers and higher scores on the attentional impulsivity dimension of BIS [i.e. 
higher attentional impulsiveness] (see table 2).  
TABLE 2 HERE 
We did not find significant correlations between neurocognitive variables and anxiety 
symptoms (see table 3). 
TABLE 3 HERE 
 4. DISCUSSION 
 The current study analyzed the association of anxiety symptoms, gambling clinical 
variables and neurocognitive variables in non-treatment seeking gamblers. We evaluated subjects 
with a wide range of gambling severity (individuals who meet 0 to 9 DSM 5 GD criteria) and 
with different levels of anxiety (HAM-A scores from 0 to 28). The use of a non-treatment 
seeking sample was important in order to achieve this spread of disease severities, to maximize 
ability to detect relationships between variables. Treatment-seeking gamblers tend to be more 
severe than gamblers in the general population (Petry et al., 2005) and therefore, the range of 
different levels of gambling activity is narrower in treatment-seeking samples. Additionally, 
treatment-seeking gamblers may present a significant selection bias. Therefore, the use of a non-
treatment seeking sample enabled us to assess the association between anxiety, gambling and 
neurocognition throughout a broad spectrum of gambling and anxiety levels.   
This study found that the severity of anxiety symptoms was associated with several 
important clinical variables, even when controlling for major depression, alcohol use disorder, 
substance-use disorder and use of nicotine. There was a positive correlation between anxiety 
severity and gambling severity measured by number of DSM 5 GD criteria met. There was also a 
positive correlation between anxiety severity and attentional impulsiveness. Participants with 
suicidality presented with higher levels of anxiety. Finally, the severity of anxiety symptoms was 
negatively correlated with quality of life.   
The number of DSM 5 criteria endorsed showed a positive correlation with anxiety 
levels. There was no significant correlation, however, between gambling severity, as measured 
by PG-YBOCS, and anxiety. The DSM-5 criteria assess symptoms over the past year whereas 
the the PG-YBOCS was designed to evaluate severity during the past 7 days. Given that anxiety 
is often a chronic condition, the DSM-5 criteria may more accurately capture the impact of these 
symptoms on gambling behavior.  
A large epidemiological study suggested that anxiety disorders usually precede GD and 
appear to trigger gambling problems (Kessler et., 2008). The longitudinal relationship between 
anxiety symptoms and gambling activity, after gambling has started, remain unclear.  In this 
context, important questions remain: do gamblers have a more harmful gambling activity due to 
higher anxiety levels? Or, does having severe gambling problems and, therefore more negative 
consequences, make gamblers feel more anxious? Future longitudinal studies should address this 
point.  
The finding that anxiety levels were positively correlated with gambling severity is 
clinically important, and proper management of anxiety may improve treatment outcomes in 
gambling problems. Psychological therapies should address anxiety while identifying reasons for 
gambling or for worsening of bets. Relaxation techniques and alternative ways to deal with 
anxiety (other than gambling) might be useful. Pharmacological approaches, such as the use of 
selective serotonin re-uptake inhibitors, may also enhance the control of anxiety. Grant and 
Potenza (2006) found that the use of escitalopram in a sample of disordered gamblers with co-
occurring anxiety significantly improved gambling and anxiety symptoms. Future clinical trials 
looking specifically at anxious gamblers are needed.  
This study observed a positive correlation between attentional impulsiveness as indexed 
by the Barratt questionnaire, and severity of anxiety symptoms; and between worse sustained 
attention on a computerized task, and severity of anxiety symptoms. Attentional impulsiveness 
has been described as an inability to keep attention/concentration (Stanford et al., 2009). When 
the BIS was first develop, attentional impulsiveness was believed to be an isolated dimension 
together with motor impulsiveness and lack of planning (Barrant, 1959). Later research 
suggested that it is an underlining construct that interacts with motor impulsiveness and lack of 
planning (Patton, 1995). Therefore, attentional impulsiveness may be considered a dimension 
that is correlated with impulsiveness in several levels (Patton, 1995).  
Attentional bias is a well characterized phenomenon in anxious individuals, who 
preferably allocate attention/focus on threatening stimuli rather than on neutral stimuli (MacLeod 
et al., 1986; Mogg & Bradley, 1998; Bar-Haim et al., 2007). This attentional bias to threat also 
leads to slower disengagement from threatening elements and, as a result of this, other non-
threatening elements tend to be less perceived (Bishop et al., 2004; Koster et al., 2004; Koster et 
al., 2006, Schofield et al., 2012). Therefore, an anxious individual who gambles may have a 
reduced focus on the gambling behavior (i.e. how to bet, how much to bet). Future studies might 
further investigate how the attentional bias interferes in gambling activity and could, particularly, 
look at possible threatening stimuli that are over-perceived during gambling behavior.   
This study also observed that severity of anxiety symptoms was positively associated 
with the presence of suicidality (Figure 1).  
 
FIGURE 1 HERE 
 
This is an important finding for several reasons. First, suicide has a huge economic 
impact in the United States. For example, in 2010, the financial losses associated with suicide 
were estimated in 44 billion American dollars/year (American Foundation for Suicide 
Prevention, 2010). Second, suicide is a top 2 leading cause of death in the United States for 
subjects aged 15-34 (Centers for Disease Control and Prevention, 2011), the population 
evaluated by this study. Third, GD and subsyndromal GD has been associated with higher rates 
of suicide ideation/attempts (Bland et al., 1993; Hodgins et al., 2006; Newman and Thompson, 
2007). Therefore, young gamblers appear to have a substantially elevated risk for suicide (age + 
gambling activity).  
Unlike the current research, the majority of previous studies that assessed suicide/risk of 
suicide in gamblers did not report a significant correlation between anxiety and suicidality. Two 
facts may explain this: a) some studies failed to assess the relationship between anxiety 
symptoms/anxiety disorders and suicide (see Hodgins et al., 2006); b) the current study evaluated 
only young adults (aged 18 to 29), a group with higher anxiety symptoms and higher suicidality 
(Martin, 2003; Centers for Disease Control and Prevention, 2011). Therefore, anxiety symptoms 
may present a higher impact on suicidality in young gamblers and c) we evaluated a broad 
spectrum of gambling activity.  
In fact, Grant and colleagues (2014) used a subsyndromal GD sample and found an 
association between suicidality and anxiety disorders. However, the assessment of suicidality did 
not control for other mental disorders as the current study did. As the correlation between GD 
and suicide ideation/attempts has been strongly attributed to co-occurring major depressive 
disorder and alcohol/substance-use disorders (Crockford and el-Guebaly, 1998; Hodgins et al., 
2006), our study strengthens the possible separate association of anxiety symptoms and 
suicidality in gamblers.  
A meta-analysis of 42 studies conducted by Kanwar et al., (2013) suggested that anxiety 
disorders are associated with higher suicidality (Kanwar et al., 2013). Better assessment of 
anxiety symptoms, particularly in gamblers with suicidality seems important in clinical practice. 
As anxiety symptoms/disorders are considered relatively treatable (Hofmann and Smits, 2008), a 
more focused management in anxious gamblers may possibly reduce suicide risk.  
Our study found that severity of anxiety was negatively correlated with quality of life. 
This finding is consistent with previous epidemiological and clinical studies that have shown that 
anxiety disorders and subthreshold forms of anxiety disorders are associated with significantly 
reduced quality of life (Markowitz et al., 1989; Weissman, 1991; Kessler et al., 1994; Spitzer et 
al., 1995; Wittchen et al., 2000, Wittchen, 2002; Mendlowicz and Stein, 2014; Zatzick et al., 
2014). On the other hand, subsyndromal GD and GD have also been associated with poorer life 
satisfaction when compared to the general population (Black et al., 2003; Grant and Kim, 2005).   
Therefore, this study reinforces the negative correlation between anxiety and decreased quality 
of life in a non-treatment seeking sample of impulsive patients.  
Quality of life is a core dimension in psychiatry treatments and, as a result of this, this 
variable has been increasingly recognized as a main outcome measure in clinical trials (Johnson 
and Temple, 1985; Group for the Advancement of Psychiatry Committee on Psychopathology, 
1994; Spitzer et al., 1995; Wilson and Cleary, 1995; Pietersma et al., 2014). Anxiety may 
selectively affect some areas of quality of life. Spitzer et al. suggested that patients with anxiety 
disorders presented decreased scores particularly in role functioning. Further research should 
look at the effects of anxiety in specific dimensions. Cognitive behavioral therapy focusing in 
training of social skills may benefit anxious gambling individuals. 
This study should be interpreted in light of its limitations. First, this research used a 
cross-sectional analysis and, therefore, causal relationships cannot be confirmed. However, the 
analysis provides reliable measures of association. Second, some of the data collected (age at 
start of recreational gambling; money lost with gambling in the last year) may be subject to 
potential recall bias, as it was collected in hindsight. Third, our sample consisted of a 
convenience sample of young adults (individuals aged 18 to 29). Therefore, caution is needed 
when generalizing our findings to broader segments of the population. Finally, our study used a 
low significance level (i.e. 0.004 for [clinical variables] and 0.007 for [neurocognitive 
variables]). Therefore, we increased the likelihood of committing Type II error. On the other 
hand, we reduced the risk of finding false-positive results. 
 This study suggests that anxiety may be associated with relevant clinical variables in the 
broad spectrum of gambling activity. Therefore, proper management of anxiety symptoms might 
improve the clinical presentation of gamblers in different areas: 1) reducing overall gambling 
severity; 2) improving attentional deficits and attempting to reduce attentional impulsiveness; 3) 
reducing risk/severity of suicidality and 4) improving quality of life.  
REFERENCES 
American Foundation for Suicide Prevention (2010). Facts and Figures. Available in 
https://www.afsp.org/understanding-suicide/facts-and-figures. Accessed Oct, 25, 2015. 
Barratt, E. S. (1959). Anxiety and impulsiveness related to psychomotor efficiency. Perceptual 
and motor skills, 9(3), 191-198. 
Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M. J., & Van Ijzendoorn, M. H. 
(2007). Threat-related attentional bias in anxious and nonanxious individuals: a meta-
analytic study. Psychological bulletin, 133(1), 1. 
Beck, A. T., & Steer, R. A. (1991). Relationship between the Beck anxiety inventory and the 
Hamilton anxiety rating scale with anxious outpatients.Journal of Anxiety Disorders, 5(3), 
213-223. 
Bishop, S., Duncan, J., Brett, M., & Lawrence, A. D. (2004). Prefrontal cortical function and 
anxiety: controlling attention to threat-related stimuli. Nature neuroscience, 7(2), 184-188. 
Black, D.W., & Moyer, T. (1998). Clinical features and psychiatric comorbidity of subjects with 
pathological gambling behavior. Psychiatric Services, 49, 1434–1439. 
Black, D. W., Moyer, T., & Schlosser, S. (2003). Quality of life and family history in 
pathological gambling. The Journal of nervous and mental disease, 191(2), 124-126. 
 Bland, R.C., Newman, S.C., Orn, H., & Stebelsky, G. (1993). Epidemiology of pathological 
gambling in Edmonton. Can J Psychiatry, 38, 108–112.  
Cambridge cognition (2015). Executive function test (CANTAB batteries). Available at 
http://www.cambridgecognition.com/academic/cantabsuite/executive-function-tests. 
Assessed Oct 25th, 2015. 
Centers for Disease Control and Prevention – CDC (2011). Web-based Injury Statistics Query 
and Reporting System [WISQARS]. National Center for Injury Prevention and Control, 
CDC (producer).  
Clark, L. (2010). Decision-making during gambling: an integration of cognitive and 
psychobiological approaches. Philosophical Transactions of the Royal Society B: Biological 
Sciences, 365(1538), 319-330. 
Crockford, D. N., & el-Guebaly, N. (1998). Psychiatric comorbidity in pathological gambling: a 
critical review. Canadian journal of psychiatry, 43(1), 43-50. 
Cunningham-Williams, R.M., Cottler, L.B., Compton III, W.M., & Spitznagel, E.L. 
(1998). Taking chances: problem gamblers and mental health disorders—results from the St. 
Louis Epidemiologic Catchment Area Study. Am J Public Health, 88, 1093–6. 
Deakin, J., Aitken, M., Robbins, T., & Sahakian, B. J. (2004). Risk taking during decision-
making in normal volunteers changes with age. Journal of the International 
Neuropsychological Society, 10(04), 590-598. 
Desai, R. A. (2004). Older adults. Pathological gambling: A clinical guide to treatment, 83-96. 
Desai, R. A., & Potenza, M. N. (2008). Gender differences in the associations between past-year 
gambling problems and psychiatric disorders. Social psychiatry and psychiatric 
epidemiology, 43(3), 173-183. 
Eisen, S. A., Slutske, W. S., Lyons, M. J., Lassman, J., Xian, H., Toomey, R. E. E. A., ... & 
Tsuang, M. T. (2001). The genetics of pathological gambling. In Seminars in clinical 
neuropsychiatry (Vol. 6, No. 3, pp. 195-204). 
Frisch, M. B. (1994). QOLI: Quality of Life Inventory: Manual and Treatment Guide. Pearson. 
Gerstein, D., Hoffmann, J., Larison, C., Engelman, L., Murphy, S., Palmer, A., ... & Hill, M. A. 
(1999). Gambling impact and behavior study. National Opinion Research Center, University 
of Chicago. 
Grall-Bronnec, M., Wainstein, L., Feuillet, F., Bouju, G., Rocher, B., Vénisse, J. L., & Sébille-
Rivain, V. (2012). Clinical profiles as a function of level and type of impulsivity in a sample 
group of at-risk and pathological gamblers seeking treatment. Journal of Gambling 
Studies, 28(2), 239-252. 
Granero, R., Fernández-Aranda, F., Aymamí, N., Gómez-Peña, M., Fagundo, A. B., Sauchelli, 
S., ... & Jiménez-Murcia, S. (2014). Subtypes of pathological gambling with concurrent 
illegal behaviors. Journal of Gambling Studies, 1-18. 
Grant, J. E., Steinberg, M. A., Kim, S. W., Rounsaville, B. J., & Potenza, M. N. (2004). 
Preliminary validity and reliability testing of a structured clinical interview for pathological 
gambling. Psychiatry Research, 128(1), 79-88. 
Grant, J. E., & Kim, S. W. (2005). Quality of life in kleptomania and pathological 
gambling. Comprehensive psychiatry, 46(1), 34-37. 
Grant, J. E., & Potenza, M. N. (2006). Escitalopram treatment of pathological gambling with co-
occurring anxiety: an open-label pilot study with double-blind discontinuation. International 
clinical psychopharmacology, 21(4), 203-209. 
Grant, J. E., Derbyshire, K., Leppink, E., & Chamberlain, S. R. (2014). Suicidality in non-
treatment seeking young adults with subsyndromal gambling disorder. Psychiatric 
quarterly, 85(4), 513-522. 
Group for the Advancement of Psychiatry Committee on Psychopathology (1994). Taking issue: 
outcomes assessment and psychiatric services (editorial). Psychiatr Serv; 45:1165. 
Hamilton, M. (1969). Diagnosis and rating of anxiety. Br J Psychiatry, 3 (special issue), 76-79. 
Hodgins, D. C., Mansley, C., & Thygesen, K. (2006). Risk factors for suicide ideation and 
attempts among pathological gamblers. American Journal on Addictions, 15(4), 303-310. 
Hofmann, S. G., & Smits, J. A. (2008). Cognitive-behavioral therapy for adult anxiety disorders: 
a meta-analysis of randomized placebo-controlled trials. The Journal of clinical 
psychiatry, 69(4), 621. 
Johnson, J. R., & Temple, R. (1985). Food and Drug Administration requirements for approval 
of new anticancer drugs. Cancer treatment reports,69(10), 1155-1159. 
Kanwar, A., Malik, S., Prokop, L. J., Sim, L. A., Feldstein, D., Wang, Z., & Murad, M. H. 
(2013). THE ASSOCIATION BETWEEN ANXIETY DISORDERS AND SUICIDAL 
BEHAVIORS: A SYSTEMATIC REVIEW AND META‐ANALYSIS. Depression and 
anxiety, 30(10), 917-929. 
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., ... & 
Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric 
disorders in the United States: results from the National Comorbidity Survey. Archives of 
general psychiatry, 51(1), 8-19. 
Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N. A., Winters, K. C., & Shaffer, 
H. J. (2008). DSM-IV pathological gambling in the National Comorbidity Survey 
Replication. Psychological medicine, 38(09), 1351-1360. 
Koster, E. H., Crombez, G., Van Damme, S., Verschuere, B., & De Houwer, J. (2004). Does 
imminent threat capture and hold attention?. Emotion, 4(3), 312. 
Koster, E. H., Crombez, G., Verschuere, B., Van Damme, S., & Wiersema, J. R. (2006). 
Components of attentional bias to threat in high trait anxiety: Facilitated engagement, 
impaired disengagement, and attentional avoidance. Behaviour research and therapy, 44(12), 
1757-1771. 
Kummer, A., Cardoso, F., & Teixeira, A. L. (2010). Generalized anxiety disorder and the 
Hamilton Anxiety Rating Scale in Parkinson's disease. Arquivos de neuro-psiquiatria, 68(4), 
495-501. 
Lawrence, A. J., Luty, J., Bogdan, N. A., Sahakian, B. J., & Clark, L. (2009). Problem gamblers 
share deficits in impulsive decision‐making with alcohol‐dependent 
individuals. Addiction, 104(6), 1006-1015. 
Lorains, F. K., Cowlishaw, S., & Thomas, S. A. (2011). Prevalence of comorbid disorders in 
problem and pathological gambling: systematic review and meta‐analysis of population 
surveys. Addiction, 106(3), 490-498. 
MacLeod, C., Mathews, A., & Tata, P. (1986). Attentional bias in emotional disorders. Journal of 
abnormal psychology, 95(1), 15. 
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988). The Hamilton Anxiety Scale: reliability, 
validity and sensitivity to change in anxiety and depressive disorders. Journal of affective 
disorders, 14(1), 61-68. 
Markowitz, J. S., Weissman, M. M., Ouellette, R., Lish, J. D., & Klerman, G. L. (1989). Quality 
of life in panic disorder. Archives of General Psychiatry, 46(11), 984-992. 
Martin, P. (2003). The epidemiology of anxiety disorders: a review. Dialogues in clinical 
neuroscience, 5(3), 281. 
Mendlowicz, M. V., & Stein, M. B. (2014). Quality of life in individuals with anxiety 
disorders. American Journal of Psychiatry. 
Mogg, K., & Bradley, B. P. (1998). A cognitive-motivational analysis of anxiety.Behaviour 
research and therapy, 36(9), 809-848. 
Morein-Zamir, S., & Sahakian, B.J. (2010). "Stop-Signal Task." In Encyclopedia of 
Psychopharmacology, pp. 1285-1285. Springer Berlin Heidelberg. 
Muelleman, R. L., DenOtter, T., Wadman, M. C., Tran, T. P., & Anderson, J. (2002). Problem 
gambling in the partner of the emergency department patient as a risk factor for intimate 
partner violence. The Journal of emergency medicine, 23(3), 307-312. 
National Gambling Impact Study Commission, & James, K. C. (1999). National Gambling 
Impact Study Commission Final Report. The Commission. 
Newman, S. C. (2007). The association between pathological gambling and attempted suicide: 
findings from a national survey in Canada. Canadian Journal of Psychiatry, 52(9), 605. 
Owen, A. M., Sahakian, B. J., Hodges, J. R., Summers, B. A., Polkey, C. E., & Robbins, T. W. 
(1995). Dopamine-dependent frontostriatal planning deficits in early Parkinson's 
disease. Neuropsychology, 9(1), 126. 
Pallanti, S., DeCaria, C. M., Grant, J. E., Urpe, M., & Hollander, E. (2005). Reliability and 
validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive 
Scale (PG-YBOCS). Journal of Gambling Studies, 21(4), 431-443. 
Patton, J. H., & Stanford, M. S. (1995). Factor structure of the Barratt impulsiveness 
scale. Journal of clinical psychology, 51(6), 768-774. 
Petry, N.M., & Kiluk, B.D. (2002). "Suicidal ideation and suicide attempts in treatment-seeking 
pathological gamblers." The Journal of nervous and mental disease 190, no. 7: 462. 
Petry, N. M., Stinson, F. S., & Grant, B. F. (2005). Comorbidity of DSM-IV pathological 
gambling and other psychiatric disorders: results from the National Epidemiologic Survey 
on Alcohol and Related Conditions. Journal of Clinical Psychiatry. 
Pietersma, S., de Vries, M., & van den Akker-van, M. E. (2014). Domains of quality of life: 
results of a three-stage Delphi consensus procedure among patients, family of patients, 
clinicians, scientists and the general public. Quality of Life Research, 23(5), 1543-1556. 
Potenza, M. N., Maciejewski, P. K., & Mazure, C. M. (2006). A gender-based examination of 
past-year recreational gamblers. Journal of Gambling Studies,22(1), 41-64. 
Sarter, M., Givens, B., & Bruno, J. P. (2001). The cognitive neuroscience of sustained attention: 
where top-down meets bottom-up. Brain research reviews,35(2), 146-160. 
Schofield, C. A., Johnson, A. L., Inhoff, A. W., & Coles, M. E. (2012). Social anxiety and 
difficulty disengaging threat: Evidence from eye-tracking. Cognition & emotion, 26(2), 300-
311. 
Shaffer, H. J., Hall, M. N., & Vander Bilt, J. (1999). Estimating the prevalence of disordered 
gambling behavior in the United States and Canada: a research synthesis. American journal 
of public health, 89(9), 1369-1376. 
Shaffer, H. J., & Korn, D. A. (2002). Gambling and related mental disorders: A public health 
analysis. Annual review of public health, 23(1), 171-212. 
Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., ... & Dunbar, 
G. C. (1998). The Mini-International Neuropsychiatric Interview (MINI): the development 
and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-
10. Journal of clinical psychiatry, 59, 22-33. 
Sher K.J., Trull T.J., Bartholow B.D. & Vieth A. (1999). Personality and alcoholism: issues, 
methods, and etiological processes. In: Leonard KE, Blane HT, eds. Psychological theories 
of drinking and alcoholism, 2nd edn. New York: Guilford, 54–105   
Slutske, W. S., Eisen, S., True, W. R., Lyons, M. J., Goldberg, J., & Tsuang, M. (2000). 
Common genetic vulnerability for pathological gambling and alcohol dependence in 
men. Archives of general psychiatry, 57(7), 666-673. 
Snaith, R. P., Baugh, S. J., Clayden, A. D., Husain, A., & Sipple, M. A. (1982). The Clinical 
Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. The British Journal 
of Psychiatry. 
Spitzer, R. L., Kroenke, K., Linzer, M., Hahn, S. R., Williams, J. B., Verloin deGruy, F., ... & 
Davies, M. (1995). Health-related quality of life in primary care patients with mental 
disorders: results from the PRIME-MD 1000 Study. Jama,274(19), 1511-1517. 
Stanford, M. S., Mathias, C. W., Dougherty, D. M., Lake, S. L., Anderson, N. E., & Patton, J. H. 
(2009). Fifty years of the Barratt Impulsiveness Scale: An update and review. Personality 
and Individual Differences, 47(5), 385-395. 
Steinberg, L., Sharp, C., Stanford, M. S., & Tharp, A. T. (2013). New tricks for an old measure: 
The development of the Barratt Impulsiveness Scale–Brief (BIS-Brief). Psychological 
assessment, 25(1), 216. 
Strong, D. R., & Kahler, C. W. (2007). Evaluation of the continuum of gambling problems using 
the DSM‐IV. Addiction, 102(5), 713-721. 
Toce-Gerstein, M., Gerstein, D. R., & Volberg, R. A. (2003). A hierarchy of gambling disorders 
in the community. Addiction, 98, 1661–1672. doi:10.1111/j.1360-0443.2003.00545.x.  
van Holst, R. J., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2010). Why gamblers 
fail to win: a review of cognitive and neuroimaging findings in pathological 
gambling. Neuroscience & Biobehavioral Reviews, 34(1), 87-107. 
Weissman, M. M. (1991). Panic disorder: Impact on quality of life. Journal of Clinical 
Psychiatry. 
Welte, J., Barnes, G., Wieczorek, W., Tidwell, M. C., & Parker, J. (2001). Alcohol and gambling 
pathology among US adults: prevalence, demographic patterns and comorbidity. Journal of 
studies on alcohol, 62(5), 706-712. 
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of 
life: a conceptual model of patient outcomes. Jama, 273(1), 59-65. 
Wittchen, H. U., Carter, R. M., Pfister, H., Montgomery, S. A., & Kessler, R. C. (2000). 
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major 
depression in a national survey. International clinical psychopharmacology, 15(6), 319-328. 
Wittchen, H. U. (2002). Generalized anxiety disorder: prevalence, burden, and cost to 
society. Depression and anxiety, 16(4), 162-171. 
Zatzick, D. F., Marmar, C. R., Weiss, D. S., Browner, W. S., Metzler, T. J., Golding, J. M., ... &  
Wells, K. B. (2014). Posttraumatic stress disorder and functioning and quality of life 
outcomes in a nationally representative sample of male Vietnam veterans. American Journal 
of Psychiatry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
TABLE 1 – Description of demographics and main clinical variables of non-treatment seeking 
gamblers (n= 143).  
 DEMOGRAPHICS 
 
Age  
% (n) or mean (SDa)  
 
24.8 (±2.9) 
Gender 
          Male 
          Female 
 
52.4 (75) 
 47.6 (68) 
Marital status  
          With partner 
          Without partner 
 
79.7 (114) 
20.3 (29) 
Educational status 
          Less than college 
          College or more 
 
 53.8 (77) 
46.2 (66) 
Occupational status 
          Studying or working 
          Unemployed 
 
81.8 (117) 
18.2 (26) 
Ethnicity  
          Caucasian 
          Non-Caucasian 
 
43.3 (61) 
56.7 (80) 
Sexual orientation 
          Heterosexual 
          Other 
 
83.9 (120) 
16.1 (23) 
 
 CLINICAL VARIABLES 
 
Anxiety symptoms severity (Hamilton Anxiety Scale) 
 
 
6.1 (±6.3) 
Age at start of regular gambling  18.9 (±3.0) 
Money lost with gambling (last year) 2,221 (±4,325) 
Average gambling frequency (times per week) 2.9 (±2.9) 
Number of DSM 5b gambling disorder criteria 2.0 (±2.6) 
PG-YBOCSc total score  7.9 (±8.1) 
a) SD = standard deviation  
b) DSM 5 = Diagnostic and statistical manual of mental disorders – fifth version 
c) PG-YBOCS = gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale  
 
  
 
TABLE 2 – Association between clinical variables and anxiety levels in non-treatment seeking 
gamblers (n = 143). 
CLINICAL VARIABLES Correlation  
Coefficienta or 
Mean HAM-Ab (SDc)  
p  
valued 
Adjusted Correlation 
Coefficiente or 
Effect size 
Adjusted 
p valuee 
Age started gambling regularly -.170 .043 -.135 .146 
Money lost with gambling (last year) .222 .008 .122 .186 
Average gambling frequency (times per week) .110 .192 .048 .604 
Number of DSM 5f gambling disorder criteria .374 < .001 .363 < .001 
PG-YBOCSg total score 
          PG-YBOCS urges subscale 
          PG-YBOCS gambling behavior subscale 
.345 
.341 
.307 
< .001 
< .001 
< .001 
.213 
.183 
.229 
.019 
.046 
.012 
Barrant Impulsiveness Scale 
          Attentional 
          Motor 
          Lack of planning 
 
.328 
.250 
.236 
 
< .001 
.003 
.005 
 
.290 
.198 
.088 
 
.001 
.032 
.344 
Legal problems due to gambling (yes/no) 2.5 (±2.1)/ 6.2 (±6.4) .437  -.036 .439 
Suicidality in past month (yes/no) 10.1 (±7.2)/ 4.5 (±5.2) < .001 .040 < .001 
Quality of life (Quality of life inventory) -.343 < .001 -.292 .001 
a) Correlation Coefficient = Spearman´s correlation coefficient   
b) Hamilton anxiety scale       
c) SD = standard deviation   
d) Significance was defined as p ≤ .004 (0.05/13 = 0.004) for clinical variables.  
e)   Adjusted for: current major depression, alcohol-use disorder, substance-use disorder and nicotine use. 
f) DSM 5 = Diagnostic and Statistical Manual of Mental Disorders – Fifth Version 
g) PG-YBOCS = gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale  
 
 
 
 
 
 
 
  
TABLE 3 – Association between neurocognitive variables and anxiety level in non-treatment 
seeking gamblers (n = 143). 
a) Correlation Coefficient = Spearman´s correlation coefficient 
b) Significance was defined as p ≤ .007 (0.05/7 = 0.007) for neurocognitive variables. 
c) Adjusted for current major depression, alcohol-use disorder, substance-use disorder and nicotine use. 
d) The following measures were used: [delay at stop signal test] = stop-signal reaction time (ms); [Intra-extra 
dimensional set shifting test] = total errors (adjusted); [Rapid visual information processing] = proportion of 
targets detected; [One touch stockings of Cambridge]: problems solved in minimum possible number of 
moves. 
 
 
 
 
 
NEUROCOGNITIVE VARIABLES Correlation  
Coefficienta  
 
p  
valueb 
Adjusted  
Correlation 
Coefficientc  
Adjusted 
p valuec 
Response inhibition (delay at the stop signal test)d .051 .546 .047 .617 
Decision-making (Cambridge gamble task) 
          Quality of decision-making 
          Overall proportion bet 
 
-.093 
.124 
 
.273 
.141 
 
-.109 
.128 
 
243 
.172 
          Risk adjustment -.131 .120 -.169 .070 
Cognitive flexibility (Intra-extra dimensional set shifting test) .170 .044 .158 .091 
Sustained Attention (rapid visual information processing)  
Executive functioning (One touch stockings of Cambridge) 
-.235 
-.209 
.005 
.014 
-.153 
-.102 
.101 
.274 
 
